H Vaughan

1.6k total citations · 1 hit paper
26 papers, 1.4k citations indexed

About

H Vaughan is a scholar working on Surgery, Genetics and Immunology. According to data from OpenAlex, H Vaughan has authored 26 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Surgery, 10 papers in Genetics and 8 papers in Immunology. Recurrent topics in H Vaughan's work include Xenotransplantation and immune response (9 papers), Animal Genetics and Reproduction (8 papers) and Monoclonal and Polyclonal Antibodies Research (7 papers). H Vaughan is often cited by papers focused on Xenotransplantation and immune response (9 papers), Animal Genetics and Reproduction (8 papers) and Monoclonal and Polyclonal Antibodies Research (7 papers). H Vaughan collaborates with scholars based in Australia, United Kingdom and Italy. H Vaughan's co-authors include Ian F. C. McKenzie, Mauro S. Sandrin, Paul Dabkowski, Peter J. Morris, Eric A. Newsholme, Pei‐Xiang Xing, J. W. Farquhar, Cori Campbell, R S Gray and W J Irvine and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

H Vaughan

26 papers receiving 1.3k citations

Hit Papers

Anti-pig IgM antibodies in human serum react predominantl... 1993 2026 2004 2015 1993 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H Vaughan Australia 13 770 529 414 376 176 26 1.4k
Jean Leif United States 23 374 0.5× 586 1.1× 919 2.2× 367 1.0× 148 0.8× 44 1.7k
Guillermo Arreaza Canada 18 344 0.4× 678 1.3× 1.0k 2.5× 166 0.4× 234 1.3× 35 1.5k
Gaby Duinkerken Netherlands 25 1.2k 1.6× 1.4k 2.6× 728 1.8× 229 0.6× 867 4.9× 38 2.0k
Gene Barbour United States 13 560 0.7× 841 1.6× 518 1.3× 143 0.4× 422 2.4× 15 1.2k
Jo Harnaha United States 13 154 0.2× 255 0.5× 816 2.0× 251 0.7× 103 0.6× 25 1.1k
Noelle B. Patterson United States 20 482 0.6× 278 0.5× 739 1.8× 256 0.7× 116 0.7× 30 1.5k
Dale R. Wegmann United States 25 1.5k 2.0× 2.4k 4.5× 1.6k 3.9× 246 0.7× 1.2k 7.0× 41 3.2k
Marielle Christ France 12 225 0.3× 566 1.1× 258 0.6× 739 2.0× 34 0.2× 21 1.2k
E K Gao United States 11 113 0.1× 145 0.3× 868 2.1× 205 0.5× 31 0.2× 13 1.2k
Helen Quill United States 19 124 0.2× 100 0.2× 1.0k 2.5× 344 0.9× 46 0.3× 33 1.5k

Countries citing papers authored by H Vaughan

Since Specialization
Citations

This map shows the geographic impact of H Vaughan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H Vaughan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H Vaughan more than expected).

Fields of papers citing papers by H Vaughan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H Vaughan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H Vaughan. The network helps show where H Vaughan may publish in the future.

Co-authorship network of co-authors of H Vaughan

This figure shows the co-authorship network connecting the top 25 collaborators of H Vaughan. A scholar is included among the top collaborators of H Vaughan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H Vaughan. H Vaughan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gibbs, Peter, et al.. (2000). MAGE-12 and MAGE-6 are frequently expressed in malignant melanoma. Melanoma Research. 10(3). 259–264. 23 indexed citations
2.
Karanikas, Vaios, Vasso Apostolopoulos, H Vaughan, et al.. (1997). Antibody and T cell responses of patients with adenocarcinoma immunized with mannan-MUC1 fusion protein.. Journal of Clinical Investigation. 100(11). 2783–2792. 228 indexed citations
3.
McKenzie, Ian F. C., Narin Osman, S. Cohney, et al.. (1996). Strategies to overcome the anti-Gal alpha (1-3)Gal reaction in xenotransplantation.. PubMed. 28(2). 537–537. 7 indexed citations
4.
McKenzie, Ian F. C., et al.. (1994). Distribution of the major xenoantigen (gal(α1–3)gal) for pig to human xenografts. Transplant Immunology. 2(2). 81–86. 70 indexed citations
5.
Vaughan, H, Paul Dabkowski, Ian F. C. McKenzie, & Mauro S. Sandrin. (1994). Biochemical analysis of the major pig xenoantigens recognised by humans.. PubMed. 26(3). 1388–9. 6 indexed citations
6.
Sandrin, Mauro S., H Vaughan, Paul Dabkowski, & Ian F. C. McKenzie. (1994). Human naturally occurring antibodies to pig xenografts.. PubMed. 26(3). 1392–1392. 1 indexed citations
7.
Sandrin, Mauro S., Effie Mouhtouris, H Vaughan, Hilary S. Warren, & Christopher R. Parish. (1993). CD48 is a low affinity ligand for human CD2.. The Journal of Immunology. 151(9). 4606–4613. 41 indexed citations
8.
Sandrin, Mauro S., et al.. (1992). Isolation and characterization of cDNA clones for mouse Ly-9. The Journal of Immunology. 149(5). 1636–1641. 48 indexed citations
9.
Vaughan, H, et al.. (1991). The isolation of cDNA clones for CD48. Immunogenetics. 33(2). 113–7. 20 indexed citations
10.
Thompson, Christopher H., H Vaughan, & Ian F. C. McKenzie. (1983). The definition of an MB related specificity by a monoclonal antibody. Human Immunology. 6(3). 133–150. 2 indexed citations
11.
Vaughan, H, Mauro S. Sandrin, Ian F. C. McKenzie, Brian D. Tait, & A. Ting. (1981). Cross-reactions of Ia antigens between mouse and man. Human Immunology. 2(2). 113–123. 3 indexed citations
12.
Sandrin, Mauro S., et al.. (1981). Serum la Levels During Tumor Growth in Mice and Humans<xref ref-type="fn" rid="fn2">2</xref><xref ref-type="fn" rid="fn3">3</xref>. JNCI Journal of the National Cancer Institute. 66(2). 279–83. 5 indexed citations
13.
Irvine, W J, C J McCallum, R S Gray, et al.. (1977). Pancreatic Islet-cell Antibodies in Diabetes Mellitus Correlated with the Duration and Type of Diabetes, Coexistent Autoimmune Disease, and HLA Type. Diabetes. 26(2). 138–147. 203 indexed citations
14.
Morris, Peter J., H Vaughan, B. Tait, & I. R. Mackay. (1977). Histocompatibility Antigens (HLA): Associations with Immunopathic Diseases and with Responses to Microbial Antigens*. Australian and New Zealand Journal of Medicine. 7(6). 616–624. 29 indexed citations
15.
Morris, P. J., H Vaughan, C J McCallum, et al.. (1976). HLA and pancreatic islet cell antibodies in diabetes [proceedings].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 2(3). 158–158. 3 indexed citations
16.
Vaughan, H, Steven Thornton, & Eric A. Newsholme. (1973). The effects of calcium ions on the activities of trehalase, hexokinase, phosphofructokinase, fructose diphosphatase and pyruvate kinase from various muscles. Biochemical Journal. 132(3). 527–535. 23 indexed citations
17.
Vaughan, H & Eric A. Newsholme. (1970). Effects of calcium ion and electron-acceptor concentrations on the activity of mitochondrial glycerol 1-phosphate dehydrogenase from insect flight muscle. Biochemical Journal. 116(4). 31P–32P. 3 indexed citations
18.
Vaughan, H & Eric A. Newsholme. (1970). The effects of calcium ions and adenosine diphosphats on the activity of nicotinamide-adenine dinucleotide-linked isocitrate dehydrogenase of muscle. Biochemical Journal. 116(4). 23P–23P. 6 indexed citations
19.
Vaughan, H & Eric A. Newsholme. (1969). The effects of Ca2+ and ADP on the activity of NAD‐linked isocitrate dehydrogenase of muscle. FEBS Letters. 5(2). 124–126. 34 indexed citations
20.
Condemi, John J., et al.. (1967). Antinuclear Antibodies Following Hydralazine Toxicity. New England Journal of Medicine. 276(9). 486–491. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026